178 related articles for article (PubMed ID: 32228296)
1. Volume Doubling Times of Lung Adenocarcinomas: Correlation with Predominant Histologic Subtypes and Prognosis.
Park S; Lee SM; Kim S; Lee JG; Choi S; Do KH; Seo JB
Radiology; 2020 Jun; 295(3):703-712. PubMed ID: 32228296
[TBL] [Abstract][Full Text] [Related]
2. Volume and Mass Doubling Time of Lung Adenocarcinoma according to WHO Histologic Classification.
Hong JH; Park S; Kim H; Goo JM; Park IK; Kang CH; Kim YT; Yoon SH
Korean J Radiol; 2021 Mar; 22(3):464-475. PubMed ID: 33169551
[TBL] [Abstract][Full Text] [Related]
3. Role of CT and PET Imaging in Predicting Tumor Recurrence and Survival in Patients with Lung Adenocarcinoma: A Comparison with the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification of Lung Adenocarcinoma.
Lee HY; Lee SW; Lee KS; Jeong JY; Choi JY; Kwon OJ; Song SH; Kim EY; Kim J; Shim YM
J Thorac Oncol; 2015 Dec; 10(12):1785-94. PubMed ID: 26473646
[TBL] [Abstract][Full Text] [Related]
4. Volume and mass doubling times of persistent pulmonary subsolid nodules detected in patients without known malignancy.
Song YS; Park CM; Park SJ; Lee SM; Jeon YK; Goo JM
Radiology; 2014 Oct; 273(1):276-84. PubMed ID: 24927472
[TBL] [Abstract][Full Text] [Related]
5. Volume Doubling Times of Pulmonary Metastases in Patients With Bone and Soft-Tissue Sarcomas: Associations With Subsequent New Metastases and Survival After Metastasectomy.
Ahn Y; Lee SM; Kim MS; Choi S; Kim S; Do KH; Seo JB
AJR Am J Roentgenol; 2022 Apr; 218(4):624-632. PubMed ID: 34730372
[No Abstract] [Full Text] [Related]
6. Close association of IASLC/ATS/ERS lung adenocarcinoma subtypes with glucose-uptake in positron emission tomography.
Nakamura H; Saji H; Shinmyo T; Tagaya R; Kurimoto N; Koizumi H; Takagi M
Lung Cancer; 2015 Jan; 87(1):28-33. PubMed ID: 25481488
[TBL] [Abstract][Full Text] [Related]
7. Solid predominant histologic subtype and early recurrence predict poor postrecurrence survival in patients with stage I lung adenocarcinoma.
Luo J; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Huang Q; Wang Y; Zheng J; Chen H
Oncotarget; 2017 Jan; 8(4):7050-7058. PubMed ID: 27732964
[TBL] [Abstract][Full Text] [Related]
8. Solitary pulmonary nodular lung adenocarcinoma: correlation of histopathologic scoring and patient survival with imaging biomarkers.
Lee HY; Jeong JY; Lee KS; Kim HJ; Han J; Kim BT; Kim J; Shim YM; Kim JH; Song I
Radiology; 2012 Sep; 264(3):884-93. PubMed ID: 22829686
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Effects of Predominant Histologic Subtypes in Resected Pulmonary Adenocarcinomas.
Yaldız D; Örs Kaya Ş; Ceylan KC; Acar A; Aydoğdu Z; Gürsoy S; Yaldız S
Balkan Med J; 2019 Oct; 36(6):347-353. PubMed ID: 31525846
[TBL] [Abstract][Full Text] [Related]
10. Prediction of the stage shift growth of early-stage lung adenocarcinomas by volume-doubling time.
Tang EK; Wu YJ; Chen CS; Wu FZ
Quant Imaging Med Surg; 2024 Jun; 14(6):3983-3996. PubMed ID: 38846271
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of the international association for the study of lung cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma in tumor recurrence and patient survival.
Hung JJ; Yeh YC; Jeng WJ; Wu KJ; Huang BS; Wu YC; Chou TY; Hsu WH
J Clin Oncol; 2014 Aug; 32(22):2357-64. PubMed ID: 24799473
[TBL] [Abstract][Full Text] [Related]
12. 18F-fluorodeoxyglucose positron emission tomographic scan in solid-type p-stage-I pulmonary adenocarcinomas: what can produce false-negative results?
Lococo F; Galeone C; Formisano D; Bellafiore S; Filice A; Annunziata T; Cesario A; Rapicetta C; Fioroni F; Ricchetti T; Paci M
Eur J Cardiothorac Surg; 2017 Apr; 51(4):667-673. PubMed ID: 28043987
[TBL] [Abstract][Full Text] [Related]
13. Differences in PET/CT standardized uptake values involvement and survival compared to histologic subtypes of lung adenocarcinoma.
Ercelep O; Alan O; Telli TA; Tuylu TB; Arıkan R; Demircan NC; Simsek ET; Babacan NA; Kaya S; Dane F; Bozkurtlar E; Ones T; Lacin T; Yumuk PF
Tumori; 2021 Jun; 107(3):231-237. PubMed ID: 32878562
[TBL] [Abstract][Full Text] [Related]
14. [Factors Influencing the Progression Trend of Early Lung Cancer and CT Findings].
Qiu Y; Mao F; Zhang H; Shen-Tu Y
Zhongguo Fei Ai Za Zhi; 2018 Oct; 21(10):793-799. PubMed ID: 30309433
[TBL] [Abstract][Full Text] [Related]
15. Breast Cancer Growth on Serial MRI: Volume Doubling Time Based on 3-Dimensional Tumor Volume Assessment.
Wang L; Luo R; Chen Y; Liu H; Guan W; Li R; Zhang Z; Duan S; Wang D
J Magn Reson Imaging; 2023 Oct; 58(4):1303-1313. PubMed ID: 36876593
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB.
Luo J; Huang Q; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Wang Y; Zheng J; Wu H; Xia W; Chen H
J Cancer Res Clin Oncol; 2016 Sep; 142(9):2031-40. PubMed ID: 27379889
[TBL] [Abstract][Full Text] [Related]
17. Stage I lung adenocarcinoma: the value of quantitative CT in differentiating pathological subtypes and predicting growth of subsolid nodules.
Xu X; Wu K; Zhao Y; Mei L
Medicine (Baltimore); 2017 Apr; 96(16):e6595. PubMed ID: 28422852
[TBL] [Abstract][Full Text] [Related]
18. A retrospective study of volume doubling time in surgically resected non-small cell lung cancer.
Mackintosh JA; Marshall HM; Yang IA; Bowman RV; Fong KM
Respirology; 2014 Jul; 19(5):755-62. PubMed ID: 24797504
[TBL] [Abstract][Full Text] [Related]
19. Micropapillary and solid subtypes of invasive lung adenocarcinoma: clinical predictors of histopathology and outcome.
Cha MJ; Lee HY; Lee KS; Jeong JY; Han J; Shim YM; Hwang HS
J Thorac Cardiovasc Surg; 2014 Mar; 147(3):921-928.e2. PubMed ID: 24199757
[TBL] [Abstract][Full Text] [Related]
20. Nonpredominant lepidic pattern correlates with better outcome in invasive lung adenocarcinoma.
Mäkinen JM; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Lappi-Blanco E; Kaarteenaho R
Lung Cancer; 2015 Dec; 90(3):568-74. PubMed ID: 26506915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
